---
title: "Medicilon: The company has fulfilled its contractual obligations, and Hongxu Biotech has yet to pay the remaining contract amount of 557,600 yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/258465157.md"
description: "Medicilon issued a statement saying that the content of the lawsuit statement published by Hongxu Bio on its WeChat official account is inconsistent with the facts. Medicilon stated that it has fulfilled its contractual obligations, but Hongxu Bio has not yet paid the remaining contract amount of 557,600 yuan and reserves the right to seek compensation"
datetime: "2025-09-23T07:00:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/258465157.md)
  - [en](https://longbridge.com/en/news/258465157.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/258465157.md)
---

# Medicilon: The company has fulfilled its contractual obligations, and Hongxu Biotech has yet to pay the remaining contract amount of 557,600 yuan

On September 23rd, Medicilon issued a statement stating that Hongxu Biotechnology recently published an article titled "Statement by Hongxu Biotechnology on Filing a Lawsuit Against Medicilon in Accordance with the Law" on its WeChat public account "Hongxu Biotechnology." The content described by Hongxu Biotechnology in the article is seriously inconsistent with the objective facts. As it involves the signing of contracts, details of performance, and the determination of breach of contract liability, these are all core disputes of the lawsuit, which await clarification by the people's court and subsequent publication. Medicilon stated in the announcement that the company has fully and appropriately fulfilled its contractual obligations. As of the date of this announcement, Hongxu Biotechnology has not paid the remaining contract amount of RMB 557,600 to the company, and the company reserves the right to pursue recovery through all legal means

### Related Stocks

- [688202.CN](https://longbridge.com/en/quote/688202.CN.md)

## Related News & Research

- [Markets are pricing in a rate hike by the European Central Bank - which one top economist sees as a 'mistake in the making'](https://longbridge.com/en/news/289420486.md)
- [Duality Biotherapeutics Advances Plan for RMB Share Listing on Shanghai Sci-Tech Board](https://longbridge.com/en/news/289260640.md)
- [15:19 ETRex's in Fort Worth Welcomes Global Soccer Fans With 104 Watch Parties During Summer's Biggest Tournament](https://longbridge.com/en/news/289504968.md)
- [Trump’s name removed from Kennedy Center website branding](https://longbridge.com/en/news/289101851.md)
- [Coram raised $35 million to turn security cameras into AI detectives](https://longbridge.com/en/news/289457582.md)